Stijn De Keukeleire

Long-term outcomes and surgical complications of endonasal endoscopic surgery in ITAC

Michael Saerens (UGent) , Tijl Vermassen (UGent) , Stijn De Keukeleire (UGent) , Jens Debacker (UGent) , Fréderic Duprez (UGent) , Philippe Deron (UGent) , Wouter Huvenne (UGent) , David Creytens (UGent) , Sylvie Rottey (UGent) and Thibaut Van Zele (UGent)

(2023) 10th European Congress on Head & Neck Oncology, Abstracts.

Add to list

Journal Article
A1
open access

The therapeutic landscape of salivary gland malignancies : where are we now?

Robbert Cleymaet (UGent) , Tijl Vermassen (UGent) , Renaat Coopman (UGent) , Hubert Vermeersch (UGent) , Stijn De Keukeleire (UGent) and Sylvie Rottey (UGent)

(2022) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 23(23).

Add to list

Journal Article
A1
open access

Tumor-infiltrating lymphocytes in head and neck cancer : ready for prime time?

Alhadi Almangush, Stijn De Keukeleire (UGent) , Sylvie Rottey (UGent) , Liesbeth Ferdinande (UGent) , Tijl Vermassen (UGent) , Ilmo Leivo and Antti A. Makitie

(2022) CANCERS. 14(6).

Add to list

PhD Thesis
open access

Dissecting TILs and PD-L1 in head and neck cancer : (still) ready for clinical practice?

Stijn De Keukeleire (UGent)

(2022)

Add to list

Journal Article
A1
open access

Concordance, correlation, and clinical impact of standardized PD-L1 and TIL scoring in SCCHN

Stijn De Keukeleire (UGent) , Tijl Vermassen (UGent) , Philippe Deron (UGent) , Wouter Huvenne (UGent) , Fréderic Duprez (UGent) , David Creytens (UGent) , Jo Van Dorpe (UGent) , Liesbeth Ferdinande (UGent) and Sylvie Rottey (UGent)

(2022) CANCERS. 14(10).

Add to list

Journal Article
A1
open access

An open‐label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma

Astrid De Meulenaere, Tijl Vermassen (UGent) , David Creytens (UGent) , Stijn De Keukeleire (UGent) , Tim Delahaye, Philippe Deron (UGent) , Fréderic Duprez (UGent) , Samson Fung, Patrick Pauwels, Liesbeth Ferdinande (UGent) , et al.

(2021) CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 14(6). p.2300-2313

Add to list

Journal Article
A1
open access

Tumour infiltrating lymphocytes in oropharyngeal carcinoma : prognostic value and evaluation of a standardised method

Stijn De Keukeleire (UGent) , Tijl Vermassen (UGent) , Astrid De Meulenaere, Philippe Deron (UGent) , Wouter Huvenne (UGent) , Fréderic Duprez (UGent) , David Creytens (UGent) , Jo Van Dorpe (UGent) , Sylvie Rottey (UGent) and Liesbeth Ferdinande (UGent)

(2021) PATHOLOGY. 53(7). p.836-843

Add to list

Favorable survival for endonasal endoscopic resection in locally advanced sinonasal intestinal type adenocarcinoma : a long-term comparative study

Stijn De Keukeleire (UGent) , Jens Debacker (UGent) , Tijl Vermassen (UGent) , Fréderic Duprez (UGent) , Philippe Deron (UGent) , Wouter Huvenne (UGent) , David Creytens (UGent) , Sylvie Rottey (UGent) and Thibaut Van Zele (UGent)

(2021) ORAL ONCOLOGY. In Oral Oncology 118(Supplement S). p.11-12

Add to list

Journal Article
A1
open access

Immuno-oncological biomarkers for squamous cell cancer of the head and neck : current state of the art and future perspectives

Stijn De Keukeleire (UGent) , Tijl Vermassen (UGent) , Elien Hilgert (UGent) , David Creytens (UGent) , Liesbeth Ferdinande (UGent) and Sylvie Rottey (UGent)

(2021) CANCERS. 13(7).

Add to list

Managing viral hepatitis in cancer patients under immune checkpoint inhibitors : should we take the risk?

Stijn De Keukeleire (UGent) , Tijl Vermassen (UGent) , Zahra Mosala Nezhad, Tessa Kerre (UGent) , Vibeke Kruse (UGent) , Hans Van Vlierberghe (UGent) , Karim Vermaelen (UGent) and Sylvie Rottey (UGent)

(2021) IMMUNOTHERAPY. 13(5). p.409-418

Academic Bibliography

Stijn De Keukeleire

Long-term outcomes and surgical complications of endonasal endoscopic surgery in ITAC

The therapeutic landscape of salivary gland malignancies : where are we now?

Tumor-infiltrating lymphocytes in head and neck cancer : ready for prime time?

Dissecting TILs and PD-L1 in head and neck cancer : (still) ready for clinical practice?

Concordance, correlation, and clinical impact of standardized PD-L1 and TIL scoring in SCCHN

An open‐label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma

Tumour infiltrating lymphocytes in oropharyngeal carcinoma : prognostic value and evaluation of a standardised method

Favorable survival for endonasal endoscopic resection in locally advanced sinonasal intestinal type adenocarcinoma : a long-term comparative study

Immuno-oncological biomarkers for squamous cell cancer of the head and neck : current state of the art and future perspectives

Managing viral hepatitis in cancer patients under immune checkpoint inhibitors : should we take the risk?

Contents

Support

Contact